Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

Pompe disease

DOI: https://doi.org/10.29296/25879979-2021-05-11
Download full text PDF
Issue: 
5
Year: 
2021

V.V. Skvortsov, A.R. Ponomareva Volgograd state medical university, Russian Health Ministry

Pompe disease (glycogenosis type II) is an autosomal recessive rare hereditary disease of a systemic nature. This disease is all about deficiency of the alpha-glucosidase enzyme which accumulate in lysosomes; a-1,4-glucosidase helps to break down glycogen. Because of mutation in the gene GAA which encodes enzyme glycogen accumulate in various organs such as heart, muscle, liver, brain. The build-up of glycogen causes dysfunction organs which can be over dead.
Keywords: 
Pompe disease
deficiency acid 1
4-glucosidase
multiple organ
diagnosis
treatment

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Sojuz pediatrov Rossii. Klinicheskie rekomendatsii. Bolezn' Pompe. 2017, S.9-19.
  2. Tsentr nervno-myshechnyh boleznej, Universitetskij gospital'nyj tsentr; Meditsinskij fakul'tet, Nitstsa, Frantsija. Pozdnjaja forma bolezni Pompe: diagnosticheskie i terapevticheskie podhody. 2012, S.22-24.
  3. Kljushnikov S.A., Zagorovskaja T.B., Kurbatov S.A., Krotenkova I.A., Zaharova E.Ju., Illarioshkin S.N. Klinicheskij sluchaj bolezni Pompe s pozdnim nachalom. Nervnye bolezni. 2015; (2): 41-42.
  4. Semjachkina A.N., Suhorukov V.S. i dr. Bolezn' nakoplenija glikogena, tip II (bolezn' Pompe) u detej. Rossijskij vestnik perinatologii i pediatrii. 2014. № 4. S.48-50.
  5. Balko O.A., Sapozhnikov V.G.. Nekotorye konstitutsional'nye osobennosti techenija hronicheskogo gastroduodenita u detej (poperechnoe issledovanie). Vrach, 2021; (1): 42-45 https://doi.org/10.29296/25877305-2021-01-08
  6. Ledentsova S.S., Guljaev N.I., Seliverstov P.V. Klinicheskaja harakteristika vnekishechnyh projavlenij i optimizatsija terapevticheskih meroprijatij u bol'nyh tseliakiej. Vrach, 2020; (12): 46-51 https://doi.org/10.29296/25877305-2020-12-10
  7. Chernousov A., Horobryh T., Zubareva M., Vychuzhanin D., Gorbunov A., Uddin N., Abdulhakimov L., Horobryh V., Gel'mutdinova E. Aktual'nye problemy hirurgicheskogo lechenija postgastrorezektsionnyh sindromov. Vrach, 2019; (6): 3-9 https://doi.org/10.29296/25877305-2019-06-01
  8. Katkova A. Interaktivnyj opros bol'nyh vospalitel'nymi zabolevanijami verhnego otdela zheludochnokishechnogo trakta s pomosch'ju avtomatizirovannoj sistemy «Elektronnaja poliklinika». Vrach, 2019; (8): 66-73 https://doi.org/10.29296/25877305-2019-08-15
  9. Materialy sajta http://www.worldpompe.org
  10. Materialy sajta https://www.rlsnet.ru
  11. Strukov V. Novyj podhod v lechenii presenil'nogo i senil'nogo osteoporoza / V. I. Strukov [i dr.] // Vrach. — 2013. — № 10. — S. 39—41
  12. Strukov V. Osteoporoz: diagnostika i effektivnoe lechenie. V. I. Strukov [i dr.] // Vrach.– 2014. – № 4. – S. 52–54.
  13. Prohorov M. Vlijanie Osteomeda na konsolidatsiju perelomov kostej / M. Prohorov, A. Kislov, V. Strukov [i dr.] // Vrach. — 2016. — № 2. — S. 68—69.
  14. Strukov V. I. Sposob umen'shenija srokov immobilizatsii pri perelomah kostej / V. I. Strukov [i dr.] // Mezhdunarodnyj zhurnal prikladnyh i fundamental'nyh issledovanij. — 2013. — № 9. — S. 124—126.
  15. Samylina I.A., Strukov V.I. Osteoprotektornye svojstva kombinatsii HDBA kompleksa s vitaminami D3 i B6 (Osteo-Vit D3) / I.A. Samylina, V.I. Strukov [i dr.] // Farmatsija. — 2020. — T.69 — № 1. — S. 48—56.
  16. Strukov V. I., Kislov A. I., Eremina N. V., Deriabina G. P., Sergeeva-Kondrachenko M. Yu., Antropov A. Yu., Kuzmina Ya. V., Tayrova K. R., Petrova E. V., Elistratov D. G., Strukova-Jones O. V. The use of Bone Tissue Non-Steroid Anabolizators in Treatment of Osteoporosis. Research J. Pharm. and Tech. 2019; 12